Zinc and Alzheimer's Disease: An Update

Nutritional Neuroscience

Volumn 2, Issue 4, 1999, Pages 191-208

  Cuajungco, Math P ^a,b,c   Lees, Gordon J ^c   Kydd, Rob R ^c   Tanzi, Rudolph E ^b   Bush, Ashley I ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Alzheimer's disease; Amyloid ; Oxidative stress; Zinc

Indexed keywords

EID: 0003168658     PISSN: 1028415X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1028415X.1999.11747277     Document Type: Article

References (223)

1. Adlard, P.A., West, A.K. and Vickers, J.C. (1998) Increased density of metallothionein I/II immunopositive cortical glial cells in the early stages of Alzheimer's disease. Neurobiology of Disease, 5, 349-356.
2. Ahn, Y.H., Kim, Y.H., Hong, S.H. and Koh, J.Y. (1998) Depletion of intracellular zinc induces protein synthesis-dependent neuronal apoptosis in mouse cortical culture. Experimental Neurology, 154, 47-56.
3. Aiken, S.P., Horn, N.M. and Saunders, N.R. (1992) Effects of amino acids on zinc transport in rat erythrocytes. Journal of Physiology, 445, 69-80.
4. Ancsin, J.B. and Kisilevsky, R. (1996) Laminin interactions important for basement membrane assembly are promoted by zinc and implicate laminin zinc finger-like sequences. Journal of Biological Chemistry, 271, 6851.
5. Andrasi, E., Farkas, E., Scheibler, H., Reffy, A. and Bezur, L. (1995) Al, Zn, Cu, Mn and Fe levels in brain in Alzheimer's disease. Archives of Gerontology and Geriatrics, 21, 89-97.
6. 2+ from brain tissue during activity. Nature, 308, 734-736.
7. Atwood, C.S., Moir, R.D., Huang, X., Scarpa, R.C., Bacarra, N.M.E., Romano, D.M., Hartshorn, M.A., Tanzi, R.E. and Bush, A.I. (1998) Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. Journal of Biological Chemistry, 273, 12817-12826.
8. Backstrom, J.R., Lim, G.P., Cullen, M.J. and Tokes, Z.A. (1996) Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1-40). Journal of Neuroscience, 16, 7910-7919.
9. Backstrom, J.R., Miller, C.A. and Tokes, Z.A. (1992) Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus. Journal of Neurochemistry, 58, 983-992.
10. Ball, M.J. (1988) Hippocampal histopathology - a critical substrate for dementia of the Alzheimer type. Interdisciplinary Topics in Gerontology: Histology and Histopathology of the Aging Brain (Ed. J. Ulrich), p. 16. Karger, Basel.
11. Baramova, E. and Foidart, J.M. (1995) Matrix metallo-proteinase family. Cell Biology International, 19, 239-242.
12. Basun, H., Forssell, L.G., Wetterberg, L. and Winbald, B. (1991) Metals and trace elements in plasma and cerebrospinal fluid in normal ageing and Alzheimer's disease. Journal of Neural Transmission, 4, 231-258.
13. Baudier, J. and Gerard, D. (1983) Ions binding to S-100 proteins: structural changes induced by calcium and zinc on S-100α and S-100β proteins. Biochemistry, 22, 3360-3369.
14. Baudier, J., Haglid, K., Haiech, J. and Gerard, D. (1983) Zinc ion binding to human brain calcium-binding proteins calmodulin and S-100β protein. Biochemical and Biophysical Research Communications, 114, 1138-1146.
15. Beach, T.G., Walker, R. and McGeer, E.G. (1989) Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia, 2, 420-436.
16. Beauchemin, D. and Kisilevsky, R. (1998) A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques. Analytical Biochemistry, 70, 1026-1029.
17. Beaulieu, C., Dyck, R. and Cynader, M. (1992) Enrichment of glutamate in zinc-containing terminals of the cat visual cortex. NeuroReport, 3, 861-864.
18. Behl, C., Davis, D.R., Lesley, R. and Schubert, D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell, 77, 817-827.
19. Berendji, D., Kolb-Bachofen, V., Meyer, K.L., Grapenthin, O., Weber, H., Wahn, V. and Kroncke, K.D. (1997) Nitric oxide mediates intracytoplasmic and intranuclear zinc release. FEBS Letters, 405, 37-41.
20. Bjorksten, B., Back, O., Gustavson, K.H., Hallmans, G., Hagglof, B. and Tarnvik, A. (1980) Zinc and immune function in Down's syndrome. Acta Paediatrica Scandinavia, 69, 183-187.
21. Blacker, D., Wilcox, M.A., Laird, N.M., Rodes, L., Horvath, S.M., Go, R.C.P., Perry, R., Watson, Jr. B., Basset, S.S., McInnis, M.G., Albert, M.S., Hyman, B.T. and Tanzi, R.E. (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer's disease. Nature Genetics, 19, 357-360.
22. Blair-West, J.R., Denton, D.A., Gibson, A.P. and McKinely, M.J. (1990) Opening the blood-brain barrier to zinc. Brain Research, 507, 6-10.
23. 2-Macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB Journal, 6, 3345-3353.
24. Bronfman, F.C., Garrido, J., Alvarez, A., Morgan, C. and Inestrosa, N.C. (1996) Laminin inhibits amyloid-β-peptide fibrillation. Neuroscience Letters, 218, 201-203.
25. Bruce, A.J., Malfroy, B. and Baudry, M. (1996) β-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proceedings of the National Academy of Sciences USA, 93, 2312-2316.
26. Brun, A., Liu, X. and Erickson, C. (1995) Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration. Neurodegeneration, 4, 171-177.
27. Burnet, F.M. (1981) A possible role of zinc in the pathology of dementia. Lancet, 1, 186-188.
28. Bush, A.I., Moir, R.D., Rosenkranz, K.M. and Tanzi, R.E. (1995) Zinc and Alzheimer's disease: technical comments. Science, 268, 1921-1923.
29. Bush, A.I., Multhaup, G., Moir, R.D., Williamson, T.G., Small, D.H., Rumble, B., Pollwein, P., Beyreuther, K. and Masters, C.L. (1993) A novel zinc(II) binding site modulates the function of the A4β amyloid protein precursor of Alzheimer's disease. Journal of Biological Chemistry, 268, 16109-16112.
30. Bush, A.I., Pettingel, W.H., Multhaup, G., Paradis, M.D., Vonsattel, J.P., Gusella, J.E, Beyreuther, K., Masters, C.L. and Tanzi, R.E. (1994a) Rapid induction of Alzheimer A amyloid formation by zinc. Science, 265, 1464-1467.
31. Bush, A.I., Pettingel, W.H., Paradis, M.D. and Tanzi, R.E. (1994b) Modulation of Aβ adhesiveness and osecretase site cleavage by zinc. Journal of Biological Chemistry, 269, 12152-12158.
32. Bush, A.I., Pettingel, W.H., Paradis, M.D., Tanzi, R.E. and Wasco, W. (1994c) The amyloid β-protein precursor and its mammalian homologues. Journal of Biological Chemistry, 269, 26618-26621.
33. Butterfield, D.A., Hensley, K., Harris, M., Mattson, M.P. and Carney, J.M. (1994) β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochemical and Biophysical Research Communications, 200, 710-715.
34. 2+, nitroxide spin probes, and synaptosomal membrane proteins. Life Sciences, 58, 217-228.
35. Cano-Gaud, D.F. and Sarkar, B. (1996) Reversible zinc exchange between metallothionein and the estrogen receptor zinc finger. FEBS Letters, 386, 1-4.
36. Castillo, G.M., Ngo, C., Cummings, J., Wight, T.N. and Snow, A.D. (1997) Perlecan binds to the β-amyloid protein (Aβ) of Alzheimer's disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability. Journal of Neurochemistry, 69, 2452-2465.
37. Chartier-Harlin, M.C., Crawford, F. and Houlden, H. (1991) Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature, 353, 844-846.
38. Cherny, R.A., Masters, C.L., Beyreuther, K., Fairlie, D., Tanzi, R.E. and Bush, A.I. (1997) The aggregation of Aβ in human brain is mediated by zinc. Society for Nauroscience Abstracts, 23(209.6) 534 (Abstract).
39. Choi, D.W. and Koh, J.Y. (1998) Zinc and brain injury. Annual Review of Neuroscience, 21, 347-375.
40. Cole, T.B., Wenzel, H.J., Kafer, K.E., Schwartzkroin, P.A. and Palmiter, R.D. (1999) Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proceedings of the National Academy of Sciences USA, 96, 1716-1721.
41. Colvin, R.A. (1998) Characterization of a plasma membrane zinc transporter in rat brain. Neuroscience Letters, 247, 147-150.
42. Constantinidis, J. (1990) Alzheimer's disease: the zinc theory. L'Encephale, 16, 231-239.
43. Constantinidis, J. (1991) The hypothesis of zinc deficiency in the pathogenesis of neurofibrillary tangles. Medical Hypothesis, 35, 319-323.
44. Cornett, C.R., Markesbery, W.R. and Ehmann, W.D. (1998) Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology, 19, 339-345.
45. Corrigan, F.M., Reynolds, G.P. and Ward, N.I. (1993) Hippocampal tin, aluminum, and zinc in Alzheimer's disease. Biometals, 6, 154
46. Crow, J.P., Beckman, J.S. and McCord, J.M. (1995) Sensitivity of the essential zinc-thiolate moiety of yeast alcohol dehydrogenase to hypochlorite and peroxynitrite. Biochemistry, 34, 3544-3552.
47. Cuajungco, M.P. and Lees, G.J. (1996) Prevention of zinc neurotoxicity by N,N,N′,N′-tetrakis(2-pyridylmethyl)-ethylenediamine (TPEN). NeuroReport, 7, 1301-1304.
48. Cuajungco, M.P. and Lees, G.J. (1997a) Zinc and Alzheimer's disease: is there a direct link? Brain Research Reviews, 23, 219-236.
49. Cuajungco, M.P. and Lees, G.J. (1997b) Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiology of Disease, 4, 137-169.
50. Cuajungco, M.P. and Lees, G.J. (1998a) Nitric oxide generators produce accumulation of chelatable zinc in the hippocampal neuronal perikarya. Brain Research, 799, 118-129.
51. Cuajungco, M.P. and Lees, G.J. (1998b) Diverse effects of metal chelating agents on the neuronal cytotoxicity of zinc in the hippocampus. Brain Research, 799, 97-107.
52. Danscher, G., Howell, G., Perez-Clausell, J. and Hertel, N. (1985) The dithizone, Timm's sulphide silver and selenium methods demonstrate a chelatable pool of zinc in CNS. Histochemistry, 83, 419-422.
53. Danscher, G., Jensen, K.B., Frederickson; C.J., Kemp, K., Andreasen, A., Juhl, S., Stoltenberg, M. and Ravid, R. (1997) Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material. Journal of Neuroscience Methods, 76, 53-59.
54. Davies, I.J.T., Musa, M. and Dormandy, T.L. (1968) Measurement of plasma zinc. Part I: In health and disease. Journal of Clinical Pathology, 21, 359-365.
55. Deibel, M.A., Ehmann, W.D. and Markesbery, W.R. (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. Journal of Neurological Science, 143, 137-142.
56. Deng, Q.S., Turk, G.C., Brady, D.R. and Smith, Q.R. (1994) Evaluation of brain element composition in Alzheimer's disease using inductively-coupled plasma mass spectrometry. Neurobiology of Aging, 15(464), S113 (Abstract).
57. +-ATPase. Canadian Journal of Biochemistry, 49, 1217-1224.
58. Dragunow, M., Faull, R.L.M., Lawlor, P., Beilharz, E.J., Singleton, K., Walker, E.B. and Mee, E. (1995) In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport, 6, 1053-1057.
59. 2-macroglobulin attenuates β-amyloid peptide 1-40 fibril formation and associated neurotoxicity in cultured fetal rat cortical neurons. Journal of Neurochemistry, 70, 1182-1188.
60. 2-macroglobulin as aβ-amyloid peptide-binding plasma protein. Journal of Neurochemistry, 69, 299-305.
61. Eagle, G.R., Zombola, R.R. and Himes, R.H. (1983) Tubulin-zinc interactions: binding and polymerization studies. Biochemistry, 22, 221-228.
62. Ebadi, M. (1991) Metallothioneins and other zinc-binding proteins in brain. Methods in Enzymology, 205, 363-387.
63. Erickson, J.C., Sewell, A.K., Jensen, L.T., Winge, D.R. and Palmiter, R.D. (1994) Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-HI (GIF). Brain Research, 649, 297-304.
64. Esch, F.S., Keim, P.S., Beattie, E.C., Blacher, R.W., Culwell, A.R., Oltersdorf, T., McClure, D. and Ward, P.J. (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science, 248, 1122-1124.
65. Fliss, H. and Menard, M. (1991) Hypochlorous acid-induced mobilization of zinc from metalloproteins. Archives of Biochemistry and Biophysics, 287, 175-179.
66. Fliss, H. and Menard, M. (1992) Oxidant-induced mobilization of zinc from metallothionein. Archives of Biochemistry and Biophysics, 293, 195-199.
67. Fliss, H., Menard, M. and Desai, M. (1991) Hypochlorous acid mobilizes cellular zinc. Canadian Journal of Pharmacology, 69, 1686-1691.
68. Frederickson, C.J. (1989) Neurobiology of zinc and zinc-containing neurons. International Review of Neurobiology, 31, 145-238.
69. Frederickson, C.J., Hernandez, M.D. and McGinty, J.F. (1989) Translocation of zinc may contribute to seizure-induced death of neurons. Brain Research, 480, 317-321.
70. Frederickson, C.J., Howell, G. and Kasarskis, E.J. (1984) The Neurobiology of Zinc. Part B: Deficiency, Toxicity and Pathology (A.R. Liss, New York).
71. Frederickson, C.J., Klitenick, M.A., Manton, W.I. and Kirkpatrick, J.B. (1983) Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat. Brain Research, 273, 335-339.
72. Frederickson, C.J., Suh, S.W., Jensen, M.S., Hayes, D.J. and Danscher, G. (1998) Temperature dependent release and translocation of zinc in hippocampus in vitro and in vivo. Society for Neuroscience Abstracts, 24(94.1) 235 (Abstract).
73. Gaskin, F., Kress, Y., Brosnan, C. and Bornstein, M. (1978) Abnormal tubulin aggregates induced by zinc sulfate in organotypic cultures of nerve tissue. Neuroscience, 3, 1117-1128.
74. Glenner, G.G. and Wong, C. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and Biophysical Research Communications, 120, 885-890.
75. Good, P.F., Werner, P., Hsu, A., Olanow, C.W. and Perl, D.P. (1996) Evidence for neuronal oxidative damage in Alzheimer's disease. American Journal of Pathology, 149, 21-28.
76. Goodwin, J.L., Uemura, E. and Cunnick, J.E. (1995) Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ. Brain Research, 692, 207-214.
77. Gottschall, P.E. and Yu, X. (1995) Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. Journal of Neurochemistry, 64, 1513-1520.
78. Griffin, W.S.T., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J., White III, C.L. and Araoz, C. (1989) Brain interleukin-1 and S-100β immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proceedings of the National Academy of Sciences USA, 86, 7611-7615.
79. Gschwind, M. and Huber, G. (1995) Apoptotic cell death induced by β-amyloid1-42 peptide is cell type dependent. Journal of Neurochemistry, 65, 292-300.
80. Hensley, K., Carney, J.M., Mattson, M.P., Aksenova, M.V., Harris, M., Wu, J.F., Floyd, R.A. and Butterfield, D.A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proceedings of the National Academy of Sciences USA, 91, 3270-3274.
81. Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M.V., Gabbita, S.P., Wu, J.F., Carney, J.M., Lovell, M.A., Markesbery, W.R. and Butterfield, D.A. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. Journal of Neuro chemistry, 65, 2146-2156.
82. Hensley, K., Maidt, M.L., Yu, Z., Sang, H., Markesbery, W.R. and Floyd, R.A. (1998) Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. Journal of Neuroscience, 18, 8126-8132.
83. Hensley, K., Tabatabaie, T., Stewart, C.A., Pye, Q. and Floyd, R.A. (1997) Nitric oxide and derived species as toxic agents in stroke, AIDS dementia, and chronic neurodegenerative disorders. Chemical Research in Toxicology, 10, 527-532.
84. Hershey, C.O., Hershey, L.A., Varnes, A., Vibhakar, S.D., Lavin, P. and Strain, W.H. (1983) Cerebrospinal fluid trace element content in dementia: clinical, radiologic and pathologic correlations. Neurology, 33, 1350-1352.
85. Hexum, T.D. (1974) Studies on the reaction catalyzed by transport (Na, K) adenosine triphosphatease-I: effects of divalent metals. Biochemical Pharmacology, 23, 3441-3447.
86. Hidalgo, J., Garcia, A., Oliva, A.M., Giralt, M., Gasull, T., Gonzalez, B., Milnerowicz, H., Wood, A. and Bremner, I. (1994) Effect of zinc, copper and glucocorticoids on metallothionein levels of cultured neurons and astrocytes from rat brain. Chemistry and Biology Interaction, 93, 197-219.
87. Holland, D.R., Cousens, L.S., Meng, W. and Matthews, B.W. (1994) Nerve growth factor in different crystal forms displays structural flexibility and reveals zinc binding sites. Journal of Molecular Biology, 239, 385-400.
88. Horn, N.M., Thomas, A.L. and Tompkins, J.D. (1995) The effect of histidine and cysteine on zinc influx into rat and human erythrocytes. Journal of Physiology, 489, 73-80.
89. Howell, G.A., Welch, M.G. and Frederickson, C.J. (1984) Stimulation-induced uptake and release of zinc in hippocampal slices. Nature, 308, 736-738.
90. Hu, J. and El-Fakahany, E.E. (1993) β-amyloid 25-35 activates nitric oxide synthase in a neuronal clone. NeuroReport, 4, 760-762.
91. Hu, J. and Van Eldik, L.J. (1996) S100β induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochimica et Biophysica Acta, 1313, 239-245.
92. Hu, J., Castets, F., Guevara, J.L. and Van Eldik, L.J. (1996) S100β stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. Journal of Biological Chemistry, 271, 2543-2547.
93. Hu, J., Ferreira, A. and Van Eldik, L.J. (1997) S100β induces neuronal cell death through nitric oxide release from astrocytes. Journal of Neurochemistry, 69, 2294-2301.
94. Huang, L. and Gitschier, J. (1997) A novel gene involved in zinc transprot is deficient in the lethal milk mouse. Nature Genetics, 17, 292-297.
95. Huang, X., Atwood, C.S., Moir, R.D., Hartshorn, M.A., Vonsattel, J.P., Tanzi, R.E. and Bush, A.I. (1997) Zinc-induced Alzheimer's Aβ1-40 aggregation is mediated by conformational factors. Journal of Biological Chemistry, 272, 26464-26470.
96. 2-Macroglobulin associates with β-amyloid peptide and prevents fibril formation. Proceedings of the National Academy of Sciences USA, 95, 3275-3280.
97. Hunter, F.E.J. and Ford, L. (1955) Inactivation of oxidative and phosphorylative systems in mitochondria by preincubation with phosphate and other ions. Journal of Biological Chemistry, 216, 357-369.
98. Hyman, B.T., Van Hoesen, G.W., Kroner, L.J. and Damasio, A.R. (1986) Perforant pathway changes and the memory impairment in Alzheimer's disease. Annals of Neurology, 20, 472-481.
99. Ii, M., Sunamoto, M., Ohnishi, K. and Ichimori, Y. (1996) β-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Research, 720, 93-100.
100. 2+ on muscle glycolysis and their reversal by histidine. Journal of Nutrional Science and Vitaminology, 26, 357-366.
101. Itoh, M., Ebadi, M. and Swanson, S. (1983) The presence of zinc-binding proteins in brain. Journal of Neurochemistry, 41, 823-829.
102. Iversen, L.L., Mortishire-Smith, R.J., Pollack, S.J. and Shearman, M.S. (1995) The toxicity in vitro of β-amyloid protein. Biochemical Journal, 311, 1-16.
103. Jacob, C., Maret, W. and Vallee, B.L. (1998) Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proceedings of the National Academy of Sciences USA, 95, 3489-3494.
104. Janicki, S. and Monteiro, M.J. (1997) Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I). Journal of Cell Biology, 139, 485-495.
105. Jiang, L.J., Maret, W. and Vallee, B.L. (1998) The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase. Proceedings of the National Academy of Sciences USA, 95, 3483-3488.
106. Kamizono, A., Nishizawa, M., Teranishi, Y., Murata, K. and Kimura, A. (1989) Identification of a gene conferring resistance to zinc and cadmium ions in the yeast Saccharomyces cerevisiae. Molecular and General Genetics, 219, 161-167.
107. Kasarskis, E.J. (1984) Zinc metabolism in normal and zinc-deficient rat brain. Experimental Neurology, 85, 114-127.
108. Kerr, J.F.R., Wyllie, A.H. and Currie, A.R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer, 26, 239-257.
109. 2+ entry produces oxidative neuronal necrosis in cortical cell cultures. European Journal of Neuroscience, 11, 327-334.
110. Kim, Y.H., Kim, E.Y., Gwag, B.J., Sohn, S. and Koh, J.Y. (1999b) Zinc-induced cortical neuronal death with features of apoptosis and necrosis: mediation by free radicals. Neuroscience, 89, 175-182.
111. Kim, T.W., Pettingell, W.H., Jung, Y.K., Kovacs, D.M. and Tanzi, R.E. (1997) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protcase. Science, 277, 373-376.
112. Koh, J.Y., Suh, S.W., Gwag, B.J., He, Y.Y., Hsu, C.Y. and Choi, D.W. (1996) The role of zinc in selective neuronal death after transient global cerebral ischemia. Science, 272, 1013-1016.
113. Koh, J.Y., Yang, L.L. and Cotman, C.W. (1990) β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Research, 533, 315-320.
114. Kress, Y., Gaskin, F., Brosnan, C. and Levine, S. (1981) Effects of zinc on the cytoskeletal proteins in the central nervous system of the rat. Brain Research, 220, 139-149.
115. Krezoski, S.K., Villalobos, J., Shaw III, C.F. and Petering, D.H. (1988) Kinetic lability of zinc bound to metallothionein in Erhlich cells. Biochemical Journal, 255, 483-491.
116. Kroncke, K.D. and Kolb-Bachofen, V. (1996) Detection of nitric oxide interaction with zinc finger proteins. Methods in Enzymology, 269, 279-284.
117. Kroncke, K.D., Fehsel, K., Schmidt, T., Zenke, F.T., Dasting, I., Wesener, J.R., Betterman, H., Breunig, K.D. and Kolb-Bachofen, V. (1994) Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of zinc finger-type yeast transcription activator LAC9. Biochemical and Biophysical Research Communications, 200, 1105-1110.
118. 2+ ions with glyceraldehyde-3-phosphate dehydro-genase from bovine heart and rabbit muscle. International Journal of Biochemistry, 24, 1501-1505.
119. 2+. Experimental Cell Research, 100, 104-110.
120. Lees, G.J. (1993) Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience, 54, 287-322.
121. Levy-Lahad, E., Wijsman, E.M., Nemens, E., Anderson, L., Goddard, K.A.B., Weber, J.L., Bird, T.D. and Schellenberg, G.D. (1995) A familial Alzheimer's disease locus on chromosome 1. Science, 269, 970-973.
122. Lim, G.P., Backstrom, J.R., Cullen, M.J., Miller, C.A., Atkinson, R.D. and Tokes, Z.A. (1996) Matrix metalloproteinase in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. Journal of Neurochemistry, 67, 251-259.
123. Link, T.A. and von Jagow, G. (1995) Zinc ions inhibit the Qp center of bovine heart mitochondrial bc1 complex by blocking a protonable group. Journal of Biological Chemistry, 270, 25001-25006.
124. Long, Y.Y., Suh, S.W., Pons, N.F., Jensen, MA, Chen, J.W., Motamedi, M., Danscher, G. and Frederickson, C.J. (1998) Chelation of extracellular zinc reduces neuronal death after head trauma. Society for Neuroscience Abstracts, 24, (675.13) 1727 (Abstract).
125. Lorenzo, A. and Yankner, B.A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proceedings of the National Academy of Sciences USA, 91, 12243-12247.
126. Lovell, M.A., Robertson, J.D., Teesdale, W.J., Campbell, J.L. and Markesbery, W.R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. Journal of Neurological Science, 158, 47-52.
127. Lui, E., Fisman, M., Wong, C. and Diaz, F. (1990) Metals and the liver in Alzheimer's disease: an investigation of hepatic zinc, copper, cadmium, and metallothionein. Journal of the American Geriatrics Society, 38, 633-639.
128. Manev, H., Kharlamov, E., Uz, T., Mason, R.P. and Cagnoli, C.M. (1997) Characterization of zinc-induced neuronal death in primary cultures of rat cerebellar granule cells. Experimental Neurology, 146, 171-178.
129. Markesbery, W.R., Ehmann, W.D., Alauddin, M. and Hossain, T.I.M. (1984) Brain trace element concentrations in aging. Neurobiology of Aging, 5, 19-28.
130. Marshak, D.R., Pesce, S.A., Stanley, L.C. and Griffin, W.S.T. (1991) Increased S-100,3 neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiology of Aging, 13,1-7.
131. Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L. and Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proceedings of the National Academy of Sciences USA, 82, 4245-4249.
132. Mattson, M.P., Begley, J.G., Mark, R.J. and Furukawa, K. (1997) Aβ25-35 induces rapid lysis of red blood cells: contrast with Aβ1-42 and examination of underlying mechanisms. Brain Research, 771, 147-153.
133. Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I. and Rydel, R.E. (1992) β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. Journal of Neuroscience, 12, 376-389.
134. McMahon, R.J. and Cousins, R.J. (1998) Mammalian zinc transporters. Journal of Nutrition, 128, 667-670.
135. Meister, A. (1983) Selective modification of glutathione metabolism. Science, 200, 472-477.
136. Meister, A. (1994) Glutathione, ascorbate, and cellular protection. Cancer Research, 54, 1969S-1975S.
137. Molina, J.A., Jimenez-Jimenez, F.J., Aguilar, M.V., Meseguer, I., Mateos-Vega, C.J., Gonzalez-Munoz, M.J., de Bustons, F., Porta, J., Orti-Pareja, M., Zurdo, M., Barrios, E. and Martinez-Para, M.C. (1998) Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. Journal of Neural Transmission, 105, 479-488.
138. Monji, A., Tashiro, K., Yoshida, I., Hayashi, Y. and Tashiro, N. (1998) Laminin inhibits Aβ40 fibril formation promoted by apolipoprotein E4 in vitro. Brain Research, 796, 171-175.
139. Muir, D. (1994) Metalloproteinase-dependent neurite outgrowth within synthetic extracellular matrix is induced by nerve growth factor. Experimental Cell Research, 210, 243-252.
140. Multhaup, G., Bush, A.I., Pollwein, P. and Masters, C.L. (1994) Interaction between the zinc(II) and the heparin binding site of the Alzheimer's disease A4β amyloid precursor protein. FEBS Letters, 355, 151-154.
141. Murrell, J., Ghetti, B. and Benson, M. (1991) A mutation in the amyloid precursor protein associated with Alzheimer's disease. Science, 254, 97-99.
142. Murtomaki, S., Risteli, J., Risteli, L., Koivisto, U.M., Johansson, S. and Liesi, P. (1992) Laminin and its neurite outgrowth-promoting domain in the brain in Alzheimer's disease and Down's syndrome patients. Journal of Neuroscience Research, 32, 261-273.
143. Mustafa, M.G., Cross, C.E., Munn, R.J. and Hardie, J.A. (1971) Effects of divalent metal ions on alveolar macrophage membrane adenosine triphosphatase activity. Journal of Laboratory and Clinical Medicine, 77, 563-571.
144. Napolitano, G., Palka, G., Grimaldi, S., Guiliani, C., Laglia, G., Calabrese, G., Satta, M.A., Neri, G. and Monaco, F. (1990) Growth delay in Down's syndrome and zinc sulphate supplementation. American Journal of Medical Genetics, 7, 63-65.
145. Narindrasorasak, S., Altman, R.A., Gonzales-DeWhitt, P., Greenberg, B.D. and Kisilevsky, R. (1995) An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Laboratory Investigation, 72, 272-282.
146. Narindrasorasak, S., Lowery, D.E., Altman, R.A., Gonzales-DeWhitt, P., Greenberg, B.D. and Kisilevsky, R. (1992) Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins. Laboratory Investigation, 67, 643-652.
147. 2-Macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. Journal of Neurochemistry, 69, 1904-1911.
148. Olanow, C.W. (1993) A radical hypothesis for neurodegeneration. Trends in Neurosciences, 16, 439-444.
149. Palmiter, R.D. and Findley, S.D. (1995) Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO Journal, 14, 639-649.
150. Palmiter, R.D., Cole, T.B. and Findley, S.D. (1996a) ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. EMBO Journal, 15, 1784-1791.
151. Palmiter, R.D., Cole, T.B., Quaife, C.A. and Findley, S.D. (1996b) ZnT-3, a putative transporter of zinc into synaptic vesicles. Proceedings of the National Academy of Sciences USA, 93, 14934-14939.
152. Pattison, S.E. and Dunn, M.F. (1976a) On the mechanism of divalent metal ion chelator induced activation of the 7S nerve growth factor esteropeptidase: activation by 2,2′,2″-terpyridine and by 8-hydroxyquinoline-5-sulfonic acid. Biochemistry, 15, 3696.
153. Pattison, S.E. and Dunn, M.F. (1976b) On the mechanism of divalent metal ion chelator induced activation of the 7S nerve growth factor esteropeptidase: thermodynamics and kinetics of activation. Biochemistry, 15, 3696-3703.
154. Pattison, S.E., Telles, S., Friar, S., Stowell, C. and Beckley, R. (1998) Zinc diffusion through lipid bilayers. Archives of Biochemistry and Biophysics, 351, 41-46.
155. Penkowa, M. and Moos, T. (1995) Disruption of the blood-brain interface in neonatal rat neocortex induces a transient expression of metallothionein in reactive astrocytes. Glia, 13, 217-227.
156. Perez-Clausell, J. and Danscher, G. (1985) Intravesicular localization of zinc in rat telencephalic boutons: a histochemical study. Brain Research, 337, 91-98.
157. Perez-Clausell, J. and Danscher, G. (1986) Release of zinc sulphide accumulation into synpatic clefts after in vivo injection of sodium sulphide. Brain Research, 362, 358-361.
158. Perry, D.K., Smyth, M.J., Stennicke, H.R., Salvesen, G.S., Duriez, P., Poirier, G.G. and Hannun, Y.A. (1997) Zinc is a potent inhibitor of the apoptotic protease, Caspase-3: a novel target for zinc in the inhibition of apoptosis. Journal of Biological Chemistry, 272, 18530-18533.
159. Pike, C.J., Walencewicz, A.J., Glabe, C.G. and Cotman, C.W. (1991a) Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. European Journal of Pharmacology, 207, 367-368.
160. Pike, C.J., Walencewicz, A.J., Glabe, C.G. and Cotman, C.W. (1991b) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Research, 563, 311-314.
161. Plantin, L.-O., Lying-Tunell, U. and Kristensson, K. (1987) Trace elements in the human central nervous system studied with neutron activation analysis. Biological Trace Element Research, 13, 69-75.
162. Potocnik, F.C., van Rensburg, S.J., Park, C., Taljaard, J.J.F. and Emsley, R.A. (1997) Zinc and platelet membrane microviscosity in Alzheimer's disease: the in vivo effect of zinc on platelet membranes and cognition. South African Medical Journal, 87, 1116-1119.
163. Prelli, F., Castano, E., Glenner, G.G. and Frangione, B. (1988) Differences between vascular and plaque core amyloid in Alzheimer's disease. Journal of Neurochemistry, 51, 648-651.
164. Price, D.L., Davis, P.B., Morris, J.C. and White, D.L. (1991) The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiology of Aging, 12, 295-312.
165. 65Zn uptake from blood into brain in the rat. Journal of Neurochemistry, 56, 485-489.
166. 2-macroglobulin complex. Journal of Biological Chemistry, 271, 8443-8451.
167. Quaife, C.A., Findley, S.D., Erickson, J.C., Froelick, G.J., Kelly, E.J., Zambrowicz, B.P. and Palmiter, R.D. (1994) Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry, 33, 7250-7259.
168. 2-macroglobulin receptor/low-density lipoprotein receptor-related protein. Annals of Neurology, 37, 211-217.
169. Reyes, J.G. (1996) Zinc transport in mammalian cells. American Journal of Physiology, 270, C401-C410
170. Roberts, S.B., Ripellino, J .A., Ingalls, K.M., Robakis, N.K. and Felsentein, K.M. (1994) Non-amyloidogenic cleavage of the β-amyloid precursor protein by an integral membrane metalloendopeptidase. Journal of Biological Chemistry, 269, 3111-3116.
171. Roher, A.E., Kasunic, T.C., Woods, A.S., Cotter, R.J., Ball, M.J. and Fridman, R. (1994) Proteolysis of Aβ peptide from Alzheimer's disease brain by gelatinase A. Biochemical and Biophysical Research Communications, 205, 1755-1761.
172. Ross, G.M., Shamovsky, I.L., Lawrence, G., Solc, M., Dostaler, S.M., Jimmo, S.L., Weaver, D.F. and Riopelle, R.J. (1997) Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins. Nature Medicine, 3, 872-877.
173. Rubin, E.H. (1990) Psychopathology of senile dementia of the Alzheimer type. Advances in Neurology (Edited by R.J. Wurtman, S. Corkin, J. Growdon and E. Ritter-Walker), p. 53. Raven Press, New York.
174. Sahu, R.N., Pandey, R.S., Subhash, M.N., Arya, B.Y.T., Padmashree, T.S. and Srinivas, K.M. (1988) CSF zinc in Alzheimer's type dementia. Biological Psychiatry, 24, 480-482.
175. Samudralwar, D.L., Diprete, C.C., Ni, B.F., Ehmann, W.D. and Markesbery, W.R. (1995) Elemental imbalances in the olfactory pathway in Alzheimer's disease. Journal of Neurological Science, 130, 139-145.
176. Sato, M. and Bremner, I. (1993) Oxygen free radicals and metallothionein. Free Radical Biology and Medicine, 14, 325-337.
177. Saunders, A.M., Strittmatter, W.J., Schmechel, D., St.George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D. and Roses, A.D. (1993) Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43, 1467-1472.
178. Selkoe, D.J., Podlisny, M.B., Gronbeck, A., Mammen, A. and Kosik, K.S. (1990) Molecular relation of amyloid filaments and paired helical filaments in Alzheimer's disease. Advances in Neurology (Edited by R.J. Wurtman S. Corkin J. Growdon and E. Ritter-Walker), p. 171. Raven Press, New York.
179. Sensi, S.L., Canzoniero, L.M.T., Yu, S.P., Ying, H.S., Koh, J.Y., Kerchner, G.A. and Choi, D.W. (1997) Measurement of intracellular free zinc in living cortical neurons: routes of entry. Journal of Neuroscience, 17, 9554-9564.
180. 2+ permeable AMPA/Kainate (CaA/K) channels triggers mitochondrial ROS generation. Society for Neuroscience Abstracts, 24(231.1) 580 (Abstract).
181. Sherrington, R., Rogaev, E.I., Liang, Y., Rogaev, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.F., Bruni, A.C., Montesi, M.P., Sorbi, S., Rainero, I., Pinessi, L., Polinsky, R.J., Wasco, W., Da Silva, H.A.R., Haines, J.L., Pericak-Vance, M.A., Tanzi, R.E., Roses, A.D., Fraser, P.E., Rommens, J.M. and St.George-Hyslop, P.H. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 375, 755-760.
182. Shivers, B.D., Hilbich, C., Multhaup, G., Salbaum, M., Beyreuther, K. and Seeburg, P.H. (1988) Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests role in cell contact. EMBO Journal, 7, 1365-1370.
183. Simons, T.J.B. (1991) Intracellular free zinc and zinc buffering in human red blood cells. Journal of Membrane Biology, 123, 63-71.
184. Skulachev, V.P., Chistyakov, V.V., Jasaitis, A.A. and Smirnova, E.G. (1967) Inhibition of the respiratory chain by zinc ions. Biochemical and Biophysical Research Communications, 26, 1-6.
185. Slomianka, L. (1992) Neurons of origin of zinc-containing pathways and the distribution of zinc-containing boutons in the hippocampal region of the rat. Neuroscience, 48, 325-352.
186. Smith, M.A., Hirai, K., Hsiao, K., Pappolla, M.A., Harris, P.L.R., Siedlak, S.L., Tabaton, M. and Perry, G. (1998) Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. Journal of Neurochemistry, 70, 2212-2215.
187. Smith, M.A., Richey Harris, P.L., Sayre, L.M., Beckman, J.S. and Perry, G. (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. Journal of Neuroscience, 17, 2653-2657.
188. Snow, A.D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J. and Wight, T.N. (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. American Journal of Pathology, 133, 456-463.
189. Snow, A.D., Willmer, J. and Kisilevsky, R. (1987) Sulfated glycosaminoglycans: a common constituent of all amyloids? Laboratory Investigation, 56, 120-123.
190. Stewart, G.R., Frederickson, C.J., Howell, G.A. and Gage, F.H. (1984) Cholinergic denervation-induced increase of chelatable zinc in mossy-fiber region of the hippocampal formation. Brain Research, 290, 43-51.
191. Su, J.H., Anderson, A.J., Cummings, B.J. and Colman, C.W. (1994) Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport, 5, 2529-2533.
192. Su, J.H., Deng, G. and Cotman, C.W. (1997) Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain. Brain Research, 774, 193-199.
193. Suh, S.W., Jensen, K.B., Jensen, M.S., Silva, D.S., Kesslak, J.P., Danscher, G. and Frederickson, C.J. (1998) Histologic evidence of a zinc role in Alzheimer's disease. Society for Neuroscience Abstracts, 24(477.13) 1217 (Abstract).
194. Takeda, A., Sawashita, J. and Okada, S. (1995) Biological half-lives of zinc and manganese in rat brain. Brain Research, 695, 53-58.
195. Takeda, A., Sawashita, J., Takefuta, S. and Okada, S. (1998) Distribution of zinc in the substantia nigra of rats treated with 6-hydroxydopamine. Biological Trace Element Research, 61, 71-78.
196. Thomas, T., Thomas, G., McLendon, C., Sutton, T. and Mullan, M. (1996) β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature, 380, 168-171.
197. Thompson, C.M., Markesbery, W.R., Ehmann, W.D., Mao, Y.-X. and Vance, D.E. (1988) Regional brain trace element studies in Alzheimer's disease. Neurotoxicology, 9, 1-7.
198. Thornalley, P.J. and Vasak, M. (1985) Possible role for metallothionein in protection against radiation-induced oxidative stress: kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochimica et Biophysica Acta, 827, 36-44.
199. Tonder, N., Johansen, F.F., Frederickson, C.J., Zimmer, J. and Diemer, N.H. (1990) Possible role of zinc in the selective degeneration of dentate hilar neurons after cerebral ischemia in the adult rat. Neuroscience Letters, 109, 247-252.
200. Uchida, Y., Takio, K., Titani, K., Ihara, Y. and Tomonaga, M. (1991) The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron, 7, 337-347.
201. Van Nostrand, W.E. (1995) Zinc(II) selectively enhances the inhibition of coagulation factor Xia by protease nexin-2/ amyloid beta-protein precursor. Thrombosis Research, 78, 43-53.
202. Van Rhijn, A.G., Prior, C.A. and Corrigan, F.M. (1990) Dietary supplementation with zinc sulphate, sodium selenite and fatty acids in early dementia of Alzheimer's type. Journal of Nutritional Medicine, 1, 259-266.
203. Vigo-Pelfrey, C., Lee, D., Keim, P., Leiberburg, I. and Schenk, D.B. (1993) Characterization of β-amyloid peptide from human cerebrospinal fluid. Journal of Neurochemistry, 61, 1965-1968.
204. Wallace, M.N., Geddes, J.G., Farquhar, D.A. and Massen, M.R. (1997) Nitric oxide synthase in reactive astrocytes adjacent to β-amyloid plaques. Experimental Neurology, 144, 266-272.
205. Ward, N.I. and Mason, J.A. (1987) Neutron activation analysis for identifying elemental status in Alzheimer's disease. Journal of Radioanalytical Nuclear Chemistry, 113, 515-526.
206. Wasco, W., Bupp, K., Magendantz, M., Gusella, J.F., Tanzi, R.E. and Solomon, F. (1992) Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer's disease-associated β precursor protein. Proceedings of the National Academy of Sciences USA, 89, 10758-10762.
207. Wasco, W., Gurubhagavatula, S., Paradis, M.D., Romano, D.M., Sisodia, S.S., Hyman, B.T., Neve, R.L. and Tanzi, R.E. (1993) Isolation and characterization of the human APLP2 gene encoding a homologue of the Alzheimer's associated amyloid β protein precursor. Nature Genetics, 5, 95-100.
208. Weldon, D.T., Rogers, S.D., Ghilardi, J.R., Finke, M.P., Cleary, J.P., O'Hare, E., Esler, W.P., Maggio, J.E. and Mantyh, P.W. (1998) Fibrillar β-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of select population of neurons in the rat CNS in vivo. Journal of Neuroscience, 18, 2173
209. Wensink, J., Molenaar, A.J., Woroniecka, U.D. and Van den Hamer, C.J.A. (1988) Zinc uptake into synaptosomes. Journal of Neurochemistry, 50, 782-789.
210. Wenstrup, D., Ehmann, W.D. and Markesbery, W.R. (1990) Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains. Brain Research, 533, 125-131.
211. Wenzel, H.J., Cole, T.B., Born, D.E., Schwartzkroin, P.A. and Palmiter, R.D. (1997) Ultrastructural localization of zinc transporter-3 (ZnT-3) to synaptic vesicle membranes within mossy fiber boutons in the hippocampus of mouse and monkey. Proceedings of the National Academy of Sciences USA, 94, 12676-12681.
212. Whitemore, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T. and DeLong, M.R. (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science, 215, 1237-1239.
213. Wiedemann, A., Paliga, K., Durrwang, U., Reinhard, F.B.M., Schucker, O., Evin, G. and Masters, C.L. (1999) Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. Journal of Biological Chemistry, 274, 5823-5829.
214. Williams, R.J.P. (1989) An introduction to the biochemistry of zinc. Zinc in human biology (Edited by C.F. Mills), p. 15. Springer Verlag, London.
215. Wolf, C.M., Morana, S.J. and Eastman, A. (1997) Zinc inhibits apoptosis upstream of ICE/CED-3 proteases rather than at the level of an endonuclease. Cell Death and Differentiation, 4, 125-129.
216. Wolozin, B., Iwasaki, K., Vito, P., Ganjei, J.K., Lacana, E., Sunderland, T., Zhao, B., Kusiak, J.W., Wasco, W. and D'Adamio, L. (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science, 274, 1710-1713.
217. Young, J.K., Garvey, J.S. and Huang, P.C. (1991) Glial immunoreactivity in the rat brain. Glia, 4, 602-610.
218. Yurchenco, P.D. and Schittny, J.C. (1990) Molecular architecture of basement membranes. FASEB Journal, 4, 1577-1590.
219. Zalewski, P.D., Forbes, I.J. and Betts, W.H. (1993) Correlation of apoptosis with change in intracellular labile Zn(II) using Zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy) acetic acid], a new specific fluorescent probe for Zn(II). Biochemical Journal, 296, 403-408.
220. Zalewski, P.D., Forbes, I.J., Seamark, R.F., Borlinghaus, R., Betts, W.H., Lincoln, S.F. and Ward, A. (1994) Flux of intracellular labile zinc during apoptosis (gene-directed cell death) revealed by a specific chemical probe, Zinquin. Chemistry and Biology, 1, 153-161.
221. Zambenedetti, P., Giordano, R. and Zatta, P. (1998) Metallothioneins are highly expressed in astrocytes and microcapillaries in Alzheimer's disease. Journal of Chemical Neuroanatomy, 15, 21-26.
222. Zeng, J., Heuchel, R., Schaffner, W. and Kagi, J.H.R. (1991a) Thionein (apometallothionein) can modulate DNA binding and transcription activation by zinc finger containing factor Sp1. FEBS Letters, 279, 310-312.
223. Zeng, J., Vallee, B.L. and Kagi, J.H.R. (1991b) Zinc transfer from transcription factor IIIA fingers to thionein clusters. Proceedings of the National Academy of Sciences USA, 88, 9984-9988.